Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Colucci

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Anticancer Research|May 4, 2005
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancerPatrizia Vici, Paolo Foggi, Giuseppe Colucci, et al.
Trials|September 10, 2020
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trialStefano Barco, Roland Bingisser, Giuseppe Colucci, et al.
Stroke|October 8, 2011
Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulantsGian Marco De Marchis, Simon Jung, Giuseppe Colucci, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panelCesare Gridelli, Matti S Aapro, Sandro Barni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
First-line treatment with epirubicin and vinorelbine in metastatic breast cancerPatrizia Vici, Giuseppe Colucci, Vittorio Gebbia, et al.
Journal of Medical Virology|May 8, 2008
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysisThorsten Kaiser, Hans C Damerow, Solveig Tenckhoff, et al.
Anticancer Research|January 18, 2003
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinomaEmanuele Naglieri, Massimo Lopez, Giorgio Lelli, et al.
Anticancer Research|May 16, 2009
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclinesPatrizia Vici, Francesco Giotta, Luigi DI Lauro, et al.
Clinical Colorectal Cancer|February 25, 2020
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802)Evaristo Maiello, Gabriele Di Maggio, Stefano Cordio, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Domenico Galetta, Michele Caruso, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Anticancer Research|May 4, 2005
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancerPatrizia Vici, Paolo Foggi, Giuseppe Colucci, et al.
Trials|September 10, 2020
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trialStefano Barco, Roland Bingisser, Giuseppe Colucci, et al.
Stroke|October 8, 2011
Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulantsGian Marco De Marchis, Simon Jung, Giuseppe Colucci, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panelCesare Gridelli, Matti S Aapro, Sandro Barni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
First-line treatment with epirubicin and vinorelbine in metastatic breast cancerPatrizia Vici, Giuseppe Colucci, Vittorio Gebbia, et al.
Journal of Medical Virology|May 8, 2008
Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: evidence for differential viral load reduction on dialysisThorsten Kaiser, Hans C Damerow, Solveig Tenckhoff, et al.
Anticancer Research|January 18, 2003
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinomaEmanuele Naglieri, Massimo Lopez, Giorgio Lelli, et al.
Anticancer Research|May 16, 2009
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclinesPatrizia Vici, Francesco Giotta, Luigi DI Lauro, et al.
Clinical Colorectal Cancer|February 25, 2020
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802)Evaristo Maiello, Gabriele Di Maggio, Stefano Cordio, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2003
Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia MeridionaleVittorio Gebbia, Domenico Galetta, Michele Caruso, et al.
Pageof 14